Most notably, Amgen announced in January it will acquire Micromet for $1.16 billionin an effort for the biotech giant to boost its oncology pipeline. Meanwhile, Celgene said it plans to purchase privately-held Avila Therapeutics for $925 million.
“I think the M&A market will continue to evolve,” said Bednar. “It is still going to include large-scale stock for stock mergers and cash acquisitions, but more and more, we’re seeing split-ups, split-offs, spin-offs and more complicated transactions.”
Earlier this week, Sears announced several moves to increase liquidity, including the sale of 11 stores to General Growth Properties for $270 million, and the spinoff of 1,250 Hometown and Outlet stores to shareholders.
“[The M&A market] will be a less plain vanilla and more complex.”
Follow JeeYeon Park on Twitter: @JeeYeonParkCNBC
Questions? Comments? Email us at firstname.lastname@example.orgPage 2 of 2 | Prev Page